Research Article, J Pharm Drug Deliv Res Vol: 6 Issue: 1
Simultaneous Quantitation of Three Genotoxic Impurities in Rizatriptan Benzoate Using Liquid Chromatography-Mass Spectrometry
| Niranjan MD*, Manish GG, Yogesh JC, Nelson R D’souza, Navin VD and Jaydeep NG | |
| Cipla Limited, L.B.S. Marg, Vikhroli (W), Mumbai-400 083, India | |
| Corresponding author : Niranjan M Deshpande Cipla Limited, L.B.S. Marg, Vikhroli (W), Mumbai-400083, India Tel: +91 9819930539, +91 22-2575 6088 E-mail: niranjan.deshpande@cipla.com |
|
| Received: March 06, 2017 Accepted: March 31, 2017 Published: April 02, 2017 | |
| Citation: Niranjan MD, Manish GG, Yogesh JC, D’souza NR, Navin VD, et al. (2017) Simultaneous Quantitation of Three Genotoxic Impurities in Rizatriptan Benzoate Using Liquid Chromatography-Mass Spectrometry. J Pharm Drug Deliv Res 6:1. doi: 10.4172/2325-9604.1000163 |
Abstract
A selective, sensitive and high throughput Liquid Chromatography Mass Spectrometry method has been developed for simultaneous quantification of three genotoxic impurities in Rizatriptan Benzoate. Three genotoxic impurities of Rizatriptan Benzoate namely 1-(4-Nitrobenzyl)-1,2,4-triazol, 4-(1H-1,2,4-Triazol1-yl methyl) benzene amine and 4-Amino-1-(4-nitrobenzyl)-1,2,4-triazolium bromide were separated on Zorbax SB-CN (150 mm × 4.6 mm, 3.5 µm) column using 10 mM ammonium acetate as buffer and acetonitrile as organic modifier in gradient composition at the flow rate of 1.0 ml/ min. All the impurities exhibited linearity with correlation of coefficient value greater than 0.990. The method was validated over the concentration range of 5 µg/g-70 µg/g for all the three impurities according to ICH guidelines. The method was successfully applied for the determination of three genotoxic impurities in Rizatriptan Benzoate drug substances.
Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi 
